143 related articles for article (PubMed ID: 10951398)
1. Hot microscopic areas of iodine-deficient euthyroid goitres contain constitutively activating TSH receptor mutations.
Krohn K; Wohlgemuth S; Gerber H; Paschke R
J Pathol; 2000 Sep; 192(1):37-42. PubMed ID: 10951398
[TBL] [Abstract][Full Text] [Related]
2. Somatic mutations in thyroid nodular disease.
Krohn K; Paschke R
Mol Genet Metab; 2002 Mar; 75(3):202-8. PubMed ID: 11914031
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of toxic thyroid adenomas and nodules: relevance of activating mutations in the TSH-receptor and Gs-alpha gene, the possible role of iodine deficiency and secondary and TSH-independent molecular mechanisms.
Derwahl M; Manole D; Sobke A; Broecker M
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S6-9. PubMed ID: 9867188
[TBL] [Abstract][Full Text] [Related]
4. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism.
Paschke R
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():129-32. PubMed ID: 8981020
[TBL] [Abstract][Full Text] [Related]
5. Gain of function TSH receptor mutations and iodine deficiency: implications in iodine prophylaxis.
Tonacchera M; Vitti P; De Servi M; Agretti P; De Marco G; Chiovato L; Pinchera A
J Endocrinol Invest; 2003; 26(2 Suppl):2-6. PubMed ID: 12762632
[TBL] [Abstract][Full Text] [Related]
6. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
[TBL] [Abstract][Full Text] [Related]
7. The detection of somatic mutations of thyrotropin receptor gene in fine needle biopsy samples from thyroid nodules.
Syrenicz A; Kurzawski G; Ciechanowicz A
Endocr Regul; 1999 Sep; 33(3):95-101. PubMed ID: 10571960
[TBL] [Abstract][Full Text] [Related]
8. [Mutations in the thyrotropin receptor gene in the pathogenesis of toxic thyroid adenomas, toxic goiter nodules and autosomal dominant hyperthyroidism].
Derwahl M
Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():25-8. PubMed ID: 10355046
[TBL] [Abstract][Full Text] [Related]
9. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter.
Tonacchera M; Agretti P; Chiovato L; Rosellini V; Ceccarini G; Perri A; Viacava P; Naccarato AG; Miccoli P; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2000 Jun; 85(6):2270-4. PubMed ID: 10852462
[TBL] [Abstract][Full Text] [Related]
10. [Molecular aetiology of nodular goitre -- consequences for therapy?].
Brauer VF; Paschke R
Zentralbl Chir; 2004 Oct; 129(5):356-62. PubMed ID: 15486785
[TBL] [Abstract][Full Text] [Related]
11. Autonomously functioning thyroid nodules in a former iodine-deficient area commonly harbor gain-of-function mutations in the thyrotropin signaling pathway.
Georgopoulos NA; Sykiotis GP; Sgourou A; Papachatzopoulou A; Markou KB; Kyriazopoulou V; Papavassiliou AG; Vagenakis AG
Eur J Endocrinol; 2003 Oct; 149(4):287-92. PubMed ID: 14514342
[TBL] [Abstract][Full Text] [Related]
12. [Molecular aspects in the pathogenesis of nodules and adenomas of the thyroid gland].
Derwahl M
Schweiz Med Wochenschr; 1994 Sep; 124(37):1613-8. PubMed ID: 7939528
[TBL] [Abstract][Full Text] [Related]
13. Toxic multinodular goiter in the elderly.
Vitti P; Rago T; Tonacchera M; Pinchera A
J Endocrinol Invest; 2002; 25(10 Suppl):16-8. PubMed ID: 12508907
[TBL] [Abstract][Full Text] [Related]
14. Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters.
Holzapfel HP; Führer D; Wonerow P; Weinland G; Scherbaum WA; Paschke R
J Clin Endocrinol Metab; 1997 Dec; 82(12):4229-33. PubMed ID: 9398745
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the TSH receptor as cause of congenital hyperthyroidism.
Schwab KO; Söhlemann P; Gerlich M; Broecker M; Petrykowski W; Holzapfel HP; Paschke R; Grüters A; Derwahl M
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():124-8. PubMed ID: 8981019
[TBL] [Abstract][Full Text] [Related]
16. Non-hyperfunctioning nodules from multinodular goiters: a minor role in pathogenesis for somatic activating mutations in the TSH-receptor and Gsalpha subunit genes.
Derrien C; Sonnet E; Gicquel I; Le Gall JY; Poirier JY; David V; Maugendre D
J Endocrinol Invest; 2001 May; 24(5):321-5. PubMed ID: 11407651
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of TSHR/Gsα mutation-negative clonal hot thyroid nodules (HNs) in a Turkish cohort.
Sancak S; Jaeschke H; Eren F; Tarcin O; Guellueoglu B; Sen LS; Sever Z; Gozu HI; Bircan R; Akalin S; Paschke R; Eszlinger M
Horm Metab Res; 2011 Jul; 43(8):562-8. PubMed ID: 21773967
[TBL] [Abstract][Full Text] [Related]
18. [Point mutations of the thyrotropin receptor gene in autonomously functioning thyroid gland nodules: correlation with clinical findings and morphology].
Lax SF; Semlitsch G; Schauer S; Zatloukal K; Langsteger W; Eber O; Höfler G
Verh Dtsch Ges Pathol; 1997; 81():145-50. PubMed ID: 9474865
[TBL] [Abstract][Full Text] [Related]
19. Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations.
Krohn K; Führer D; Holzapfel HP; Paschke R
J Clin Endocrinol Metab; 1998 Jan; 83(1):130-4. PubMed ID: 9435429
[TBL] [Abstract][Full Text] [Related]
20. Activating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiter.
Tonacchera M; Vitti P; Agretti P; Giulianetti B; Mazzi B; Cavaliere R; Ceccarini G; Fiore E; Viacava P; Naccarato A; Pinchera A; Chiovato L
Thyroid; 1998 Jul; 8(7):559-64. PubMed ID: 9709907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]